PubMed

Design control considerations for biologic-device combination products.

PMID: 28088344 · 2017-01-11

D, a, v, e, , A, n, d, e, r, s, o, n, ;, , R, o, g, e, r, , L, i, u, ;, , J, , A, n, a, n, d, , S, u, b, r, a, m, o, n, y, ;, , J, o, n, , C, a, m, m, a, c, k

ЖурналAdvanced drug delivery reviews

Год2017-01-11

PMID28088344

Аннотация

Combination products are therapeutic and diagnostic medical products that combine drugs, devices, and/or biological products with one another. Historically, biologics development involved identifying efficacious doses administered to patients intravenously or perhaps by a syringe. Until fairly recently, there has been limited focus on developing an accompanying medical device, such as a prefilled syringe or auto-injector, to enable easy and more efficient delivery. For the last several years, an

Официальный источник

Открыть в PubMed →

Данные получены из PubMed / NCBI. Полный текст и наиболее актуальную информацию всегда смотрите в официальной записи.